High importance
Oct 13, 2026
This research highlights the potential of OCT as a noninvasive tool for monitoring treatment responses in HHT, potentially guiding more effective laser therapies and improving patient outcomes.
To evaluate the effectiveness of low energy long pulse 1064 nm Nd:YAG laser treatment for vascular anomalies associated with hereditary hemorrhagic telangiectasia (HHT) using optical coherence tomography (OCT).
The treatment resulted in a clinical improvement with an 89% decrease in vascular density and a shallower vascular plexus depth, confirming successful intervention without adverse effects at lower fluences (50-55 J/cm2).
A case study involved a 79-year-old female with HHT who received three treatments with the Nd:YAG laser for a vascular lesion. OCT was employed to visualize cutaneous vasculature and monitor treatment effects before and after laser interventions.
The study is a single case report, limiting generalizability. Further studies with larger sample sizes are needed to validate these findings across different populations and lesion types.
For your doctor:
PMID: 42871767
DOI: 10.1155/crdm/8810881
Hereditary hemorrhagic telangiectasia (HHT) is an autosomal-dominant disorder characterized by vascular lesions with variable treatment responses. Optical coherence tomography (OCT) can provide noninvasive bedside visualization of cutaneous vasculature and monitoring of treatment response. A 79-year-old female with HHT underwent three treatments for a vascular lesion on her right fifth digit that had been resistant to pulsed dye laser, using a long pulse 1064 nm neodymium-yttrium aluminum garnet laser. At lower fluences (50-55 J/cm2), clinical improvement was achieved without adverse effects. OCT imaging performed before and after treatment demonstrated an 89% decrease in vascular density and shallower vascular plexus depth posttreatment. OCT can be used to objectively measure changes in vascular characteristics in response to laser treatment.